Ventas (NYSE:VTR) issued an update on its FY18 earnings guidance on Friday morning. The company provided EPS guidance of $4.03-4.07 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.02. Ventas also updated its FY 2018 guidance to $4.03-4.07 EPS.
VTR stock opened at $61.39 on Friday. The company has a market capitalization of $21.88 billion, a price-to-earnings ratio of 15.12, a PEG ratio of 4.55 and a beta of -0.02. The company has a debt-to-equity ratio of 1.00, a current ratio of 0.56 and a quick ratio of 0.56. Ventas has a one year low of $46.55 and a one year high of $64.96.
Ventas (NYSE:VTR) last announced its quarterly earnings data on Friday, October 26th. The real estate investment trust reported $0.99 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.97 by $0.02. Ventas had a net margin of 19.90% and a return on equity of 4.56%. The company had revenue of $936.54 million during the quarter, compared to analysts’ expectations of $920.19 million. During the same period in the previous year, the company earned $1.71 EPS. The business’s quarterly revenue was up 4.1% compared to the same quarter last year. As a group, sell-side analysts expect that Ventas will post 4.05 EPS for the current year.
In related news, EVP T Richard Riney sold 13,708 shares of the company’s stock in a transaction that occurred on Friday, August 31st. The shares were sold at an average price of $60.00, for a total value of $822,480.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.40% of the stock is currently owned by corporate insiders.
Ventas, Inc, an S&P 500 company, is a leading real estate investment trust. Its diverse portfolio of approximately 1,200 assets in the United States, Canada and the United Kingdom consists of seniors housing communities, medical office buildings, life science and innovation centers, inpatient rehabilitation and long-term acute care facilities, health systems and skilled nursing facilities.
Read More: Should you buy a closed-end mutual fund?
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.